Monday, August 22nd, 2011
Adcetris (brentuximab vedotin), recently FDA approved for Hodgkin lymphoma and systemic anaplastic large cell lymphoma, may cost over $100,000 for a course of treatment, or $4,500 per vial. According to marketers and manufacturers, Seattle Genetics, patients typically need three vials in one dose, and from seven to nine doses per ...
Posted in Health | Comments Off
Thursday, August 11th, 2011
The US FDA has approved Complera (emtricitabine/rilpivirine/tenofovir disoproxil fumarate), a once-a-day single tablet for patients with HIV-1 infection who are new to treatment (treatment-naïve patients), makers and marketers Gilead Sciences Inc. announced today. Complera contains three antiretroviral drugs in one tablet: Truvada - a Gilead medication, a fixed-dose combination of ...
Posted in Health | Comments Off
Tuesday, July 19th, 2011
Yahoo! Inc., the most-visited U.S. Web portal, reported sales that fell short of estimates as marketers shunned its pages in favor of rival sites.
Find more info about Yahoo Sales Miss Estimates as Rivals Siphon Display-Ad Revenue photos videos pictures. read more
Posted in Business & Finance | Comments Off
Monday, March 14th, 2011
When Apple Inc. releases a product, the store lines are typically led by fanboys clamoring to be first with the latest gadget. At the downtown San Francisco store for the iPad 2 debut, the gray market got there first.
Find more info about IPad 2 Lines Led by Gray Marketers photos ...
Posted in Business & Finance | Comments Off
Monday, March 14th, 2011
When Apple Inc. releases a product, the store lines are typically led by fanboys clamoring to be first with the latest gadget. At the downtown San Francisco store for the iPad 2 debut, the gray market got there first.
Find more info about IPad2 Lines Led by Gray Marketers photos videos ...
Posted in Business & Finance | Comments Off
